A single center analysis of malignancies in first kidney graft recipients.
Busnach
G
G
Department of Nephrology, Niguarda Ca' Granda Hospital, Milano, Italy. Omnibus@tiscalinet.it
Minetti
E
E
Colombo
V
V
Sommaruga
E
E
Muti
G
G
Civati
G
G
D000328:Adult; D000367:Age Factors; D000704:Analysis of Variance; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002277:Carcinoma / Q000209:etiology; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008232:Lymphoproliferative Disorders / Q000209:etiology; D008297:Male; D009369:Neoplasms / Q000209:etiology*; D012514:Sarcoma, Kaposi / Q000209:etiology
D000961:Antilymphocyte Serum; D015415:Biomarkers; D007166:Immunosuppressive Agents; D003404:Creatinine